Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-κB signaling

Journal of Cellular Biochemistry

Volumn 111, Issue 4, 2010, Pages 899-910

  Wong, Vincent Kam Wai ^a   Cheung, Simon Shiu Fai ^a   Li, Ting ^a   Jiang, Zhi Hong ^a   Wang, Jing Rong ^a   Dong, Hang ^a   Yi, Xiao Qin ^a   Zhou, Hua ^a   Liu, Liang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Anti cancer; Apoptosis; Asian ginseng; Cell cycle arrest; LLC 1 carcinoma

Indexed keywords

ALCOHOL; ASIAN GINSENG EXTRACT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLINE; GINSENG EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG INHIBITION; DRUG POTENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MALE; MODULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ASIA; CARCINOMA, LEWIS LUNG; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUPEPTINS; MALE; MICE; MICE, INBRED C57BL; MITOSIS; NF-KAPPA B; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MUS; PANAX GINSENG;

EID: 78049250867     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22778     Document Type: Article

References (50)

1. Abraham RT. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15: 2177-2196.
2. Ahn JY, Choi IS, Shim JY, Yun EK, Yun YS, Jeong G, Song JY. 2006. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol 36: 37-45.
3. Amato P, Christophe S, Mellon PL. 2002. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9: 145-150.
4. Block KI, Mead MN. 2003. Immune system effects of echinacea, ginseng, and astragalus: A review. Integr Cancer Ther 2: 247-267.
5. Brown L, Benchimol S. 2006. The involvement of MAPK signaling pathways in determining the cellular response to p53 activation: Cell cycle arrest or apoptosis. J Biol Chem 281: 3832-3840.
6. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115.
7. Chang TK, Chen J, Benetton SA. 2002. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab Dispos 30: 378-384.
8. Chang YS, Seo EK, Gyllenhaal C, Block KI. 2003. Panax ginseng: A role in cancer therapy? Integr Cancer Ther 2: 13-33.
9. Chang TL, Ding HY, Kao YW. 2008. Role of ginsenoside Rd in inhibiting 26S proteasome activity. J Agric Food Chem 56: 12011-12015.
10. Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY. 2008. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: Role of early growth response-1 expression. Cancer Res 68: 1369-1377.
11. Domingo-Domenech J, Pippa R, Tapia M, Gascon P, Bachs O, Bosch M. 2008. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. Breast Cancer Res Treat 112: 53-62.
12. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632.
13. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. 2006. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experience. World J Gastroenterol 12: 1336-1345.
14. Gao N, Budhraja A, Cheng S, Yao H, Zhang Z, Shi X. 2009. Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase. Clin Cancer Res 15: 140-149.
15. Gohji K, Fidler IJ, Tsan R, Radinsky R, von Eschenbach AC, Tsuruo T, Nakajima M. 1994. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells. Int J Cancer 58: 380-384.
16. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
17. Hasegawa H, Uchiyama M. 1998. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med 64: 696-700.
18. Helms S. 2004. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 9: 259-274.
19. Ho TC, Chen SL, Yang YC, Chen CY, Feng FP, Hsieh JW, Cheng HC, Tsao YP. 2008. 15-Deoxy-delta(12, 14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKs and p53. J Biol Chem 283: 30273-30288.
20. Huang YC, Chen CT, Chen SC, Lai PH, Liang HC, Chang Y, Yu LC, Sung HW. 2005. A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharm Res 22: 636-646.
21. Hur JM, Yun HJ, Yang SH, Lee WY, Joe MH, Kim D. 2008. Gliotoxin enhances radiotherapy via inhibition of radiation-induced GADD45a, p38, and NFkappaB activation. J Cell Biochem 104: 2174-2184.
22. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. 1999. p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 96: 2147-2152.
23. Karin M, Cao Y, Greten FR, Li ZW. 2002. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
24. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. 2009. p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 48: 24-37.
25. Koepp DM, Harper JW, Elledge SJ. 1999. How the cyclin became a cyclin: Regulated proteolysis in the cell cycle. Cell 97: 431-434.
26. Kondo Y, Kanzawa T, Sawaya R, Kondo S. 2005. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5: 726-734.
27. Lee YJ, Jin YR, Lim WC, Ji SM, Cho JY, Ban JJ, Lee SK. 2003a. Ginsenoside Rc and Re stimulate c-fos expression in MCF-7 human breast carcinoma cells. Arch Pharm Res 26: 53-57.
28. Lee YJ, Jin YR, Lim WC, Park WK, Cho JY, Jang S, Lee SK. 2003b. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res 26: 58-63.
29. Li T, Wong VK, Yi XQ, Wong YF, Zhou H, Liu L. 2009. Pseudolaric acid B suppresses T lymphocyte activation through inhibition of NF-kappaB signaling pathway and p38 phosphorylation. J Cell Biochem 108(1): 87-95.
30. Liang HC, Chen CT, Chang Y, Huang YC, Chen SC, Sung HW. 2005. Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration. Tissue Eng 11: 835-846.
31. Lin KM, Hsu CH, Rajasekaran S. 2008. Angiogenic evaluation of ginsenoside Rg 1 from Panax ginseng in fluorescent transgenic mice. Vasc Pharmacol 49: 37-43.
32. Liu S, Bishop WR, Liu M. 2003. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 6: 183-195.
33. Lu Pingcheng ZZ, Kunfu Z, Jianwei C. 1997. Effects of ginseng and ginseng with TNF on tumor. J Nanjing Univ Tradit Chin Med 13(6): 344-345.
34. Noguchi M, Shimosato Y. 1995. The development and progression of adenocarcinoma of the lung. Cancer Treat Res 72: 131-142.
35. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
36. Richardson PG, Mitsiades C, Hideshima T, Anderson KC. 2006. Bortezomib: Proteasome inhibition as an effective anticancer therapy. Annu Rev Med 57: 33-47.
37. Shibata S. 2001. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 16(Suppl): S28-S37.
38. Sizemore N, Leung S, Stark GR. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19: 4798-4805.
39. Sparreboom A, Cox MC, Acharya MR, Figg WD. 2004. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. J Clin Oncol 22: 2489-2503.
40. Sun Y, Chen J, Rigas B. 2009. Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death. Carcinogenesis 30: 93-100.
41. Traenckner EB, Wilk S, Baeuerle PA. 1994. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 13: 5433-5441.
42. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. 2002. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 137: 889-903.
43. Wilkie A, Cordess C. 1994. Ginseng-A root just like a carrot? J R Soc Med 87: 594-595.
44. Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC. 2005. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin Cancer Res 11: 6002-6011.
45. Wu GS. 2004. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 3: 156-161.
46. Xiaoguang C, Hongyan L, Xiaohong L, Zhaodi F, Yan L, Lihua T, Rui H. 1998. Cancer chemopreventive and therapeutic activities of red ginseng. J Ethnopharmacol 60: 71-78.
47. Xie FY, Zeng ZF, Huang HY. 2001. Clinical observation on nasopharyngeal carcinoma treated with combined therapy of radiotherapy and ginseng polysaccharide injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 21: 332-334.
48. Yu LC, Chen SC, Chang WC, Huang YC, Lin KM, Lai PH, Sung HW. 2007. Stability of angiogenic agents, ginsenoside Rg1 and Re, isolated from Panax ginseng: In vitro and in vivo studies. Int J Pharm 328: 168-176.
49. Yun TK. 2003. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523-524: 63-74.
50. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671.